Human mitogen-activated protein kinase kinase 4 as a candidate tumor suppressor

Cancer Research

Volumn 57, Issue 19, 1997, Pages 4177-4182

  Teng, David H F ^a,c   Perry III, William L ^a   Hogan, James K ^b   Baumgard, Michelle ^a   Bell, Russell ^a   Berry, Simin ^a   Davis, Thaylon ^a   Frank, David ^a   Frye, Cheryl ^a   Hattier, Thomas ^a   Hu, Rong ^a   Jammulapati, Srikanth ^a   Janecki, Teresa ^a   Leavitt, Amber ^a   Mitchell, Jeffrey T ^a   Pero, Ralph ^a   Sexton, David ^a   Schroeder, Marianne ^a   Su, Pi Hsia ^a   Swedlund, Brad ^a   Kyriakis, John M ^b   Avruch, Joseph ^b   Bartel, Paul ^a   Wong, Alexander K C ^a   Oliphant, Arnold ^a   Thomas, Alun ^a   Skolnick, Mark H ^a   Tavtigian, Sean V ^a   more..

^a Myriad Genetic Laboratories   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c Myriad Genetic Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CHROMOSOME 17P; ENZYME ACTIVITY; GENE LOCUS; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; MISSENSE MUTATION; NONSENSE MUTATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STRESS; TUMOR SUPPRESSOR GENE;

DNA, NEOPLASM; GENES, TUMOR SUPPRESSOR; GENOTYPE; HEAT-SHOCK PROTEINS; HUMANS; LUNG NEOPLASMS; MAP KINASE KINASE 4; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; NEOPLASM PROTEINS; NEOPLASMS; PANCREATIC NEOPLASMS; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; SEQUENCE DELETION; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 0030757691     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stocken, E., Day, R. S., III, Johnson, B. E., and Skolnick, M. H. A cell cycle regulator potentially involved in genesis of many tumor types. Science (Washington DC), 264: 436-440, 1994.
2. Wooster, R., Bignell, G., Lancaster, J., Swift, S., Seal, S., Mangion, J., Collins, N., Gregory, S., Gumbs, C., Micklem, G., Barfoot, R., Hamoudi, R., Patel, S., Rice, C., Biggs, P., Hashim, Y., Smith, A., Connor, F., Arason, A., Gudmundsson, J., Ficenec, D., Kelsell, D., Ford, D., Tonin, P. Bishop, D. T., Spurr, N. K., Ponder, B., Eeles, R., Peto, J., Devilee, P., Cornelisse, C., Lynch, H., Narod, S., Lenior, G., Eglisson, V., Barkadottir, R. B., Easton, D. F., Bentley, D. R., Futreal, P. A., Ashworth. A., and Stratton, M. R. Identification of the breast cancer susceptibility gene, BRCA2. Nature (Lond.), 378: 789-792, 1995.
3. Tavtigian, S. V., Simard, J., Rommens, J., Couch, F., Shattuck-Eidens, D., Neuhausen, S., Merajver, S., Thorlacius, S., Offit, K., Stoppa-Lyonnet, D., Belanger, C., Bell, R., Berry, S., Bogden, R., Chen, Q., Davis, T., Dumont, M., Frye, C., Hattier, T., Jammulapati, S., Janecki, T., Jiang, P., Kehrer, R., Leblanc, J. F., Mitchell, J. T., McArthur-Morrison, J., Nguyen, K., Peng, Y., Samson, C., Schroeder, M., Snyder, S. C., Steele, L., Stringfellow, M., Stroup, C., Swedlund, B., Swensen, J., Teng, D., Thomas, A., Tran, T., Tranchant, M., Weaver-Feldhaus, J., Wong, A. K. C., Shizuya, H., Eyfjord, J. E., Cannon-Albright, L., Labrie, L., Skolnick, M. H., Weber, B., Kamb, A., and Goldgar, D. E. The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat. Genet., 12: 333-337, 1996.
4. Steck, P. A., Pershouse, M. A., Jasser, S. A., Yung, W. K. A., Lin, H., Ligon, A. H., Langford, L. A., Baumgard, M. L., Hattier, T., Davis, T., Fyre, C., Hu, R., Swedlund, B., Teng, D. H. F., and Tavtigian, S. Identification of a candidate tumor suppressor gene. MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat. Genet., 15: 356-362, 1997.
5. Li, J. Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., Bigner, S. H., Giovanella, B. C., Ittmann, M., Tycko, B., Hibhoosh, H., Wigler, M. H., and and Parsons, R. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science (Washington DC), 275: 1943-1947, 1997.
6. Schutte, M., da Costa, L. T., Hahn, S. A., Moskaluk, C., Hoque, A. T., Rozenblum, E., Weinstein, C. L., Bittner, M., Meltzer, P. S., Trent, J. M., Yeo, C. J., Hruban, R. H., and Kern, S. E. Identification by representational difference analysis of a homozygous deletion in pancreatic carcinoma that lies within the BRCA2 region. Proc. Natl. Acad. Sci. USA. 92: 5950-5954, 1995.
7. Vogelstein, B., Fearon, E. R., Kern, S. E., Hamilton, S. R., Preisinger, A. C., Nakamura, Y., and White, R. Allelotype of colorectal carcinomas. Science (Washington DC), 244: 207-211, 1989.
8. Derijard, B., Raingeaud, J., Barrett, T., Wu, I. H., Han, J., Ulevitch, R. J., and Davis, R. J. Independent human MAP kinase signal transduction pathways defined by MEK and MKK isoforms. Science (Washington DC), 267: 682-685, 1995.
9. Lin, A., Minden, A., Martinetto, H., Claret, F. X., Lange-Carter, C., Mercurio, F., Johnson, G. L., and Karin, M. Identification of a dual specificity kinase that activates the Jun kinases and p38-Mpk2. Science (Washington DC), 268: 286-290, 1995.
10. Couch, F. J., Rommens, J. M., Neuhausen, S. L., Belanger, C., Dumont, M., Abel, K., Bell, R., Berry, S., Bogden, R., Cannon-Albright, L., Farid, L., Frye, C., Hattier, T., Janecki, T., Jiang, P., Kehrer, R., Leblanc, J. F., McArthur-Morrison, J., Meney, D., Miki, Y., Peng, Y., Samson, C., Schroeder, M , Snyder, S. C., Stringfellow, M., Stroup, C., Swedlund, B., Swensen, J., Teng, D., Thakur, S., Tran, T., Tranchant, M., Weaver-Feldhaus, J., Wong, A. K. C., Shizuya, H., Labrie, F., Skolnick, M. H., Goldgar, D. E., Kamb, A., Weber, B. L., Tavtigian, S. V., and Simard, J. Generation of an integrated transcription map of the BRCA2 region on chromosome 13q12-q13. Genomics, 36: 86-99, 1996.
11. Teng, D. H. F., Bogden, R., Mitchell, J., Baumgard, M., Bell, R., Berry, S., Davis, T., Ha, P. C., Kehrer, R., Jammulapati, S., Chen, Q., Offit, K., Skolnick, M. H., Tavtigian, S. V., Jhanwar, S., Swedlund, B., Wong, A. K. C., and Kamb, A. Low incidence of BRCA2 mutation in breast carcinoma and other cancers. Nat. Genet., 13: 241-248, 1996.
12. Hirai, S., Izawa, M., Osada, S., Spyrou, G., and Ohno, S. Activation of the JNK pathway by distantly related protein kinases, MEKK and MUK. Oncogene, 12: 641-650, 1996.
13. Sanchez, I., Hughes, R. T., Mayer, B. J., Yee, K., Woodgett, J. R., Avruch, J., Kyriakis, J. M., and Zon, L. I. Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating transcription factor c-Jun. Nature (Lond.), 372: 794-798, 1994.
14. Hanks, S. K., Quinn, A. M., and Hunter, T. The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. Science (Washington DC), 241: 42-52, 1988.
15. Zheng, C. F., and Guan, K. L. Cloning and characterization of two distinct human extracellular signal-regulated kinase activator kinases, MEK1 and MEK2. J. Biol. Chem., 268: 11435-11439, 1993.
16. English, J. M., Vanderbilt, C. A., Xu, S., Marcus, S., and Cobb, M. H. Isolation of MEK5 and differential expression of alternatively spliced forms. J. Biol. Chem., 270: 28897-28902, 1995.
17. Moriguchi, T., Kuroyanagi, N., Yamaguchi, K., Gotoh, Y., Irie, K., Kano, T., Shirakabe, K., Muro, Y., Shibuya, H., Matsumoto, K., Nishida, E., and Hagiwara, M. A novel kinase cascade mediated by mitogen-activated protein kinase kinase 6 and MKK3. J. Biol. Chem., 271: 13675-13679, 1996.
18. Ruggeri, B., Zhang, S. Y., Caamano, J., DiRado, M., Flynn, S. D., and Klein-Szanto, A. J. Human pancreatic carcinomas and cell lines reveal frequent and multiple alterations in the p53 and Rb-1 tumor-suppressor genes. Oncogene, 7: 1503-1511, 1992.
19. Redston, M. S., Caldas, C., Seymour, A. B., Hruban, R. H., da Costa, L., Yeo, C. J., and Kern, S. E. p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions. Cancer Res., 54: 3025-3033, 1994.
20. Waskiewicz, A. J., and Cooper, J. Mitogen and stress response pathways: MAP kinase cascades and phosphatase regulation in mammals and yeast. Curr. Opin. Cell Biol., 7: 798-805, 1995.
21. Kyriakis, J. M., and Avruch, J. Sounding the alarm: protein kinase cascades activated by stress and inflammation. J. Biol. Chem., 271: 24313-24316, 1996.
22. Xia, Z., Dickens, M., Raingeaud, J., Davis, R. J., and Greenberg, M. E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science (Washington DC), 270: 1326-1331, 1995.
23. Chen, Y-R., Meyer, C. F., and Tan, T-H. Persistent activation of c-Jun N-terminal kinase 1 (JNK1) in γ radiation-induced apoptosis. J. Biol. Chem., 271: 631-634, 1996.
24. Verheij, M., Bose, R., Lin, X. H., Yao, B., Jarvis, W. D., Grant, S., Birrer, M. J., Szabo, E., Zon, L. I., Kyriakis, J. M., Haimovitz-Friedman, A., Fuks, Z., and Kolesnick, R. N. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature (Lond.), 380: 75-79, 1996.
25. Cuvillier, O., Pirianov, G., Kleuser, B., Vanek, P. G., Coso, O. A., Gutkind, S., and Spiegel, S. Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature (Lond.), 381: 800-803, 1996.
26. Johnson, N. L., Gardner, A. M., Diener, K. M., Lange-Carter, C. A., Gleavy, J., Jarpe, M. B., Minden, A., Karin, M., Zon, L. I., and Johnson, G. L. Signal transduction pathways regulated by mitogen-activated/extracellular response kinase kinase kinase induce cell death. J. Biol. Chem., 271: 3229-3237, 1996.
27. Liu, Z-G., Hsu, H., Goeddel, D. V., and Karin, M. Dissection of INF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell, 87: 565-576, 1996.
28. Ichijo, H., Nishida, E., Irie, K., ten Dijke, P., Sailoh, M., Moriguchi, T., Takagi, M., Matsumoto, K., Miyazono, K., and Gotoh, Y. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signalling pathways. Science (Washington DC), 275: 90-94, 1997.
29. Chiarugi, V., and Ruggiero, M. Role of thee cancer "master genes" p53, bcl-2, and c-myc on the apoptotic process. Tumori, 82: 205-209, 1996.